Levels of Complement Anaphylatoxin C5a in Pulmonary Effluent Fluid of Infants at Risk for Chronic Lung Disease and Effects of Dexamethasone Treatment

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Pediatric Research

• Publication date

  1993-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1203/00006450-199311000-00006PMID 8284093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals.

  2015cited by this paper
• Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance.

  2015cited by this paper
• Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome.

  1993cited by this paper
• Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease.

  1993cited by this paper
• Activation of the Plasma Kallikrein-Kinin System in Respiratory Distress Syndrome

  1992cited by this paper
• Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia.

  1992cited by this paper
• Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.

  1992cited by this paper
• A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.

  1991cited by this paper
• Corticosteroid inhibition of airway microvascular leakage.

  1991cited by this paper
• Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia.

  1991cited by this paper
• Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial.

  1989cited by this paper
• Biosynthesis of the third and fifth complement components by isolated human lung cells.

  1989cited by this paper
• Neutrophil chemotactic factors in bacterial pneumonia.

  1989cited by this paper
• A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

  1989cited by this paper
• Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

  1988cited by this paper
• Anaphylatoxin formation in sepsis.

  1988cited by this paper
• Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia.

  1987cited by this paper
• Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids.

  1987cited by this paper
• Activation of the complement system in the adult respiratory distress syndrome.

  1987cited by this paper
• Complement Activation in Cystic Fibrosis Respiratory Fluids: in Vivo and in Vitro Generation of C5a and Chemotactic Activity

  1986cited by this paper
• Elastase in tissue injury.

  1985cited by this paper
• Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury.

  1985cited by this paper
• Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia.

  1985cited by this paper
• Dexamethasone inhibits generation in inflammatory sites of the chemotactic activity attributable to leukotriene B4.

  1984cited by this paper
• Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.

  1983cited by this paper
• Lung inflammation: role of endogenous chemotactic factors in attracting polymorphonuclear granulocytes.

  1983cited by this paper
• Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.

  1983cited by this paper
• Neutrophils and the adult respiratory distress syndrome.

  1983cited by this paper
• Complement biosynthesis by human bronchoalveolar macrophages.

  1983cited by this paper
• Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

  1982cited by this paper
• Methylprednisolone inhibits the alternative and amplification pathways of complement

  1982cited by this paper
• Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia.

  1981cited by this paper
• In vitro activation of complement by isolated human heart subcellular membranes.

  1979cited by this paper
• Cyclophosphamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages.

  1979cited by this paper
• Complement fragments, alveolar macrophages, and alveolitis.

  1979cited by this paper
• How corticosteroids work.

  1975cited by this paper
• Lecithin-sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy.

  1973cited by this paper
• Effect of cortisone therapy on serum complement components.

  1973cited by this paper

• Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

  2023cites this paper
• Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Permissive Hypercapnia

  2017cites this paper
• Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.

  2017influential citation
• PREVENTIVE AND THERAPEUTIC APPROACHES FOR BRONCHOPULMONARY DYSPLASIA-AN UPDATE

  2012cites this paper
• Developmental innate immunoinsufficiency: Comparison of term neonatal neutrophil proteinases and complement component levels relative to adults

  2012cites this paper
• Chapter 36 – Immunology of the Fetus and Newborn

  2012cites this paper
• Choriodecidual Group B Streptococcal Inoculation Induces Fetal Lung Injury without Intra-Amniotic Infection and Preterm Labor in Macaca nemestrina

  2011cites this paper
• Complement 4 Levels as Early Predictors of Poor Response to Surfactant Therapy in Respiratory Distress Syndrome

  2005cites this paper
• Complement 4 levels as early predictors of poor response to surfactant therapy in respiratory distress syndrome.

  2005cites this paper
• Chapter 35 – Immunology of the Fetus and Newborn

  2005cites this paper
• Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress

  2005cites this paper
• Role of cytokines in hyperoxia mediated inflammation in the developing lung.

  2003cites this paper
• Inflammation and bronchopulmonary dysplasia.

  2003cites this paper
• Proinflammatory Cytokines in the Developing Lung 702 analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates

  2003cites this paper
• Generation of C5a by phagocytic cells.

  2002cites this paper
• Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease

  2002cites this paper
• Microbial infection and inflammation in the development of chronic lung disease of prematurity.

  2002cites this paper
• Role of Complement in Acute Lung Injury

  2001cites this paper
• New Insights into the Pathogenesis of Pulmonary Inflammation in Preterm Infants

  2001cites this paper
• Ureaplasma urealyticum induced pulmonary inflammation in the development of chronic lung disease of prematurity

  2001cites this paper
• Infection, neutrophils, and hematopoietic growth factors in the pathogenesis of neonatal chronic lung disease.

  2000cites this paper
• INFLAMMATORY MEDIATORS IN NEONATAL LUNG DISEASE

  2000cites this paper
• Complement and Contact Activation Related to Surfactant Response in Respiratory Distress Syndrome

  1999cites this paper
• Role of Complement in Endothelial Cell Activation

  1999cites this paper
• Inflammatory mechanisms in neonatal chronic lung disease

  1999cites this paper
• Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia.

  1998cites this paper
• Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates

  1998cites this paper
• Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease

  1998cites this paper
• Comparison of Pulmonary Inflammatory Mediators in Preterm Infants Treated with Intermittent Positive Pressure Ventilation or High Frequency Oscillatory Ventilation 1

  1998cites this paper
• Bronchopulmonary dysplasia in the 1990s: a review for the pediatrician.

  1997cites this paper
• Activation of Circulating Polymorphonuclear Leukocytes in Preterm Infants with Severe Idiopathic Respiratory Distress Syndrome

  1996cites this paper
• Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome.

  1996cites this paper
• Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.

  1996cites this paper
• Increase in Interleukin (IL)-1β and IL-6 in Bronchoalveolar Lavage Fluid Obtained from Infants with Chronic Lung Disease of Prematurity

  1996cites this paper
• Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.

  1995cites this paper
• Bronchoalveolar inflammatory pathophysiology of bronchopulmonary dysplasia.

  1995cites this paper
• [Pathogenesis of bronchopulmonary dysplasia].

  1995cites this paper